Create
Log in
Enquire now
ESSA Pharma
ESSA Pharma is developing treatments for prostate cancer.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Company
Organization
CEO
David R. Parkinson
0
CIK Number
1,027,702
Legal Name
ESSA Pharma Inc.
Company Operating Status
Active
Country
United States
0
Canada
0
Crunchbase URL
crunchbase.com/organiz...a-pharma
Email Address
info@essapharma.com
0
Founded Date
January 1, 2009
Full Address
400 Oyster Point Blvd., Suite 520 South San Francisco, CA 94080 United States
0
700 Milam St., Suite 1300 Houston, TX 77002 United States
0
999 West Broadway, Suite 720 Vancouver, BC V5Z 1K5, Canada
0
Headquarters
Massachusetts
Industry
Biomedical engineering
Synthetic chemistry
Engineering
Technology
Biology
Biotechnology
Investors
Deerfield Management
Biotechnology Value Fund (BVF Partners)
Pfizer Breakthrough Growth Initiative
Frazier Healthcare Partners
Pfizer
Point72
Vivo Capital
Ridgeback Capital
CAM Capital
Avidity Partners
•••
IRS Number
43,030,815
Latest Funding Round Date
July 2022
Latest Funding Round Amount (USD)
13,333,000
Latest Funding Type
Initial public offering (IPO)
LinkedIn URL
@company/essa-pharma
Location
Canada
South San Francisco, California
0
Vancouver
0
Houston
0
United States
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Phone Number
+17783310962
0
Pitchbook URL
pitchbook.com/profiles...107834-05
SIC Code
2,834
Exchange
Nasdaq
0
Stock Symbol
EPIX
0
Ticker Symbol
EPIX
Total Funding Amount (USD)
280,433,000
Twitter URL
@EssaPharma
Official Website
essapharma.com
Wikidata ID
Q30268939
Find more companies like ESSA Pharma
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE